News

Why TSLY Should Be Avoided Here

Discover why TSLY's covered-call strategy on Tesla underperforms TSLA, with declining share prices & low implied volatility.

Pfizer: Shares Are Cheap, But They Could Get Even Cheaper Next Year

I remain bearish on Pfizer due to pricing pressures from IRA/340B and a looming 2026 patent cliff, despite Q2 2025 earnings beat.